Allergy immunotherapy is associated with a reduced risk of asthma severity progression and lower airway infections. Results from the REACT-study

C. Porsbjerg (Copenhagen, Denmark), B. Fritzsching (Heidelberg, Germany), N. Freemantle (London, United Kingdom), S. Buchs (Hoersholm, Denmark), J. Larsen (Hoersholm, Denmark), M. Contoli (Ferrara, Italy)

Source: International Congress 2022 – Update on clinical trials in allergy, asthma and COPD

Session: Update on clinical trials in allergy, asthma and COPD
Session type: Thematic Poster
Number: 3203

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Porsbjerg (Copenhagen, Denmark), B. Fritzsching (Heidelberg, Germany), N. Freemantle (London, United Kingdom), S. Buchs (Hoersholm, Denmark), J. Larsen (Hoersholm, Denmark), M. Contoli (Ferrara, Italy). Allergy immunotherapy is associated with a reduced risk of asthma severity progression and lower airway infections. Results from the REACT-study. 3203

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.